A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Catequentinib (Primary) ; Irinotecan (Primary) ; Palbociclib (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer; Small cell lung cancer
- Focus Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 16 Aug 2021 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Jul 2021 to 30 Aug 2021.
- 16 Aug 2021 Planned initiation date changed from 1 Jul 2021 to 30 Aug 2021.
- 25 Jun 2021 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Jun 2021 to 1 Jul 2021.